Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease related to metabolic syndrome. No standard pharmacological treatment has yet been established. We retrospectively evaluated the efficacy of pemafibrate in 16 NAFLD patients (11 men and 5 women; median age, 59 years; range, 27–81 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Suguru, Sugihara, Takaaki, Kihara, Takuya, Matsuki, Yukako, Nagahara, Takakazu, Takata, Tomoaki, Kitao, Sonoko, Okura, Tsuyoshi, Yamamoto, Kazuhiro, Isomoto, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700575/
https://www.ncbi.nlm.nih.gov/pubmed/34943553
http://dx.doi.org/10.3390/diagnostics11122316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700575/
https://www.ncbi.nlm.nih.gov/pubmed/34943553
http://dx.doi.org/10.3390/diagnostics11122316

Ejemplares similares